+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Urolithiasis Management Devices Market by Device Type, Treatment Type, Device Material, Application, End User - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5336626
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Urolithiasis Management Devices Market is projected to reach USD 1.27 Billion in 2026. It is expected to continue growing at a CAGR of 5.96%, reaching USD 1.81 Billion by 2032.

Urolithiasis management devices address a high-burden clinical area spanning kidney, ureteral, bladder, and urethral stones. Demand is supported by well-documented risk factors, including dehydration, obesity, diabetes, high dietary sodium intake, low fluid intake, and recurrent stone disease. Epidemiology studies consistently show that kidney stone prevalence has increased over recent decades in many countries, while recurrence remains common, making durable, minimally invasive, and cost-efficient treatment pathways a priority for hospitals and ambulatory surgery centers.

The device landscape includes ureteroscopes, holmium and thulium fiber laser lithotripsy systems, stone retrieval baskets, access sheaths, ureteral stents, nephroscopes, percutaneous nephrolithotomy instruments, and extracorporeal shock wave lithotripsy platforms. Adoption is reinforced by guideline-backed movement toward endoscopic stone treatment, shorter inpatient stays, improved visualization, reduced retreatment needs, and devices that help lower operative time while supporting higher stone-free rates.

Transformative Shifts in the Urolithiasis Devices Landscape

The urolithiasis management devices landscape is being reshaped by the shift from open surgery to minimally invasive endourology. Flexible and single-use ureteroscopes are reducing cross-contamination concerns and repair-related downtime, while high-power laser systems, thulium fiber laser platforms, and advanced fibers improve fragmentation and dusting efficiency. Hospitals are also prioritizing integrated imaging, irrigation control, suction-assisted access, and digital workflow tools that help standardize procedure quality.

A second transformation is occurring in care delivery. More stone procedures are moving into outpatient and same-day settings where device reliability, fast turnover, sterilization efficiency, and predictable supply are essential. Procurement decisions increasingly evaluate total cost of ownership, device reprocessing requirements, surgeon learning curves, service support, and compatibility with existing operating room infrastructure rather than unit price alone.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence urolithiasis management across diagnosis, procedure planning, and follow-up. AI-enabled imaging tools can support stone detection, measurement, density estimation, segmentation, and automated reporting on CT, which is widely regarded as the reference imaging modality for suspected urinary stones. These capabilities may help clinicians select between surveillance, medical expulsive therapy, ureteroscopy, shock wave lithotripsy, or percutaneous nephrolithotomy.

The cumulative impact of AI will be strongest where it connects imaging, electronic health records, device data, and recurrence-risk models. Predictive analytics can identify patients at higher risk of repeat stones, while automated documentation and operative analytics can improve quality reporting, benchmarking, and procedure planning. Industry leaders should treat AI as a clinical decision-support layer that must be validated, explainable, cybersecurity-ready, and integrated within regulated medical device frameworks.

Key Regional Insights

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in endourology capacity, private hospital networks, and advanced diagnostic imaging. Large patient pools, hot climates in several subregions, urban dietary shifts, and increasing metabolic disease burden support durable demand for ureteroscopic and laser lithotripsy solutions. North America remains a technology-intensive region led by the United States and Canada, where established urology practices, reimbursement access, ambulatory surgery centers, and early adoption of single-use scopes support advanced device utilization.

Europe benefits from guideline-driven care, strong academic urology centers, and broad adoption of minimally invasive stone treatment across Germany, France, Italy, Spain, and the United Kingdom. Latin America is gaining momentum through Brazil and Mexico, though adoption varies with reimbursement, public-sector funding, hospital infrastructure, and specialist access. The Middle East shows strong demand in GCC countries due to high stone prevalence associated with climate, dehydration, and lifestyle risk factors, while Africa presents a long-term access opportunity where affordability, training, equipment maintenance, and infrastructure remain decisive.

Key Group Insights

ASEAN markets are characterized by uneven but rising access to endoscopic urology, with Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines showing different procurement patterns tied to public-private healthcare mix, specialist distribution, and hospital investment cycles. GCC countries are strategically important because high temperatures, dehydration risk, and sustained investments in advanced hospitals create favorable conditions for lithotripsy systems, ureteroscopes, stents, access sheaths, and procedure-specific disposables.

The European Union offers regulatory harmonization through the Medical Device Regulation, but manufacturers must account for stronger clinical evidence expectations, post-market surveillance, and traceability requirements. BRICS countries represent scale, local manufacturing potential, and price-sensitive tenders, especially in China, India, Brazil, and South Africa, while Russia presents procurement and supply-chain complexity. G7 markets remain innovation leaders with high specialist density, sophisticated reimbursement pathways, and strong procedure standardization, while NATO-aligned countries often benefit from mature procurement systems, training infrastructure, and cross-border clinical collaboration.

Key Country Insights

The United States leads in advanced urolithiasis management device adoption due to high procedural volumes, ambulatory care expansion, broad use of endoscopic stone management, and early uptake of digital ureteroscopy and laser platforms. Canada emphasizes evidence-based procurement and equitable access across provinces, while Mexico is expanding private-sector demand for minimally invasive urology. Brazil is Latin America’s largest opportunity, supported by specialist centers, growing hospital investment, and rising demand for ureteroscopy, laser lithotripsy, and percutaneous stone procedures.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show strong use of guideline-based endoscopic stone management, with Germany particularly important for device quality expectations, hospital purchasing power, and advanced surgical infrastructure. Russia remains relevant but faces procurement complexity and supply-chain constraints. China and India provide high-volume growth potential as hospital infrastructure expands, imaging access improves, and domestic manufacturers scale. Japan, South Korea, and Australia favor advanced, quality-focused technologies supported by sophisticated urology communities, strong clinical training, and well-developed regulatory systems.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize devices that demonstrate measurable improvements in stone-free rates, operative efficiency, safety, infection control, durability, and lifecycle cost. Product portfolios should combine capital equipment with recurring-use accessories, including laser fibers, baskets, access sheaths, ureteral stents, nephrostomy tools, and irrigation solutions, while offering clear training pathways for urologists, nurses, and operating room teams.

Manufacturers should localize market access strategies by region, strengthen clinical evidence generation, and prepare for stricter post-market data expectations. Partnerships with hospitals, ambulatory surgery centers, and academic urology programs can accelerate adoption and improve procedural consistency. Organizations that integrate AI-ready imaging data, service analytics, cybersecurity controls, and procedure support into compliant platforms will be better positioned for premium differentiation.

Research Methodology

This executive summary is built on secondary research, clinical guideline review, regulatory intelligence, and triangulation of publicly available information from urology associations, government health agencies, peer-reviewed literature, hospital procurement trends, and medical device regulatory bodies. Sources considered include established clinical guidance from the American Urological Association and European Association of Urology, epidemiological literature on stone disease incidence and recurrence, and regulatory frameworks such as U.S. FDA requirements and the EU Medical Device Regulation.

The methodology evaluates demand drivers, technology shifts, care settings, competitive positioning, regional access conditions, reimbursement indicators, and compliance requirements. Insights are validated through cross-comparison of clinical, commercial, and policy evidence to ensure that conclusions remain data-backed, practical, and relevant for decision-makers in urolithiasis management devices.

Conclusion

The urolithiasis management devices market is moving toward minimally invasive, digitally enabled, and evidence-driven care. Rising stone burden, recurring disease, and growing demand for efficient outpatient procedures continue to support adoption of ureteroscopy, laser lithotripsy, stone retrieval tools, stents, percutaneous nephrolithotomy instruments, and related endourology platforms.

Competitive advantage will depend on clinical performance, reliability, training support, regulatory readiness, infection prevention, service quality, and total cost of ownership. Companies that align product innovation with regional access realities and AI-enabled clinical workflows can capture sustainable growth while improving patient outcomes across global stone disease care pathways.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Urolithiasis Management Devices Market, by Device Type
7.1. Guidewires
7.2. Lithotripters
7.3. Stents
7.4. Ureteroscopes
8. Urolithiasis Management Devices Market, by Treatment Type
8.1. Extracorporeal Shock Wave Lithotripsy
8.2. Intracorporeal Lithotripsy
8.3. Percutaneous Nephrolithotomy
9. Urolithiasis Management Devices Market, by Device Material
9.1. Metal-Based Devices
9.2. Polymer-Based Devices
10. Urolithiasis Management Devices Market, by Application
10.1. Bladder Stones
10.2. Kidney Stones
10.3. Ureteral Stones
11. Urolithiasis Management Devices Market, by End User
11.1. Ambulatory Surgical Centers
11.2. Hospitals
11.3. Specialty Clinics
12. Asia-Pacific Urolithiasis Management Devices Market
13. Europe Urolithiasis Management Devices Market
14. North America Urolithiasis Management Devices Market
15. Latin America Urolithiasis Management Devices Market
16. Africa Urolithiasis Management Devices Market
17. Middle East Urolithiasis Management Devices Market
18. NATO Urolithiasis Management Devices Market
19. G7 Urolithiasis Management Devices Market
20. BRICS Urolithiasis Management Devices Market
21. European Union Urolithiasis Management Devices Market
22. ASEAN Urolithiasis Management Devices Market
23. GCC Urolithiasis Management Devices Market
24. China Urolithiasis Management Devices Market
25. United States Urolithiasis Management Devices Market
26. Japan Urolithiasis Management Devices Market
27. India Urolithiasis Management Devices Market
28. Germany Urolithiasis Management Devices Market
29. United Kingdom Urolithiasis Management Devices Market
30. Australia Urolithiasis Management Devices Market
31. France Urolithiasis Management Devices Market
32. South Korea Urolithiasis Management Devices Market
33. Italy Urolithiasis Management Devices Market
34. Canada Urolithiasis Management Devices Market
35. Russia Urolithiasis Management Devices Market
36. Brazil Urolithiasis Management Devices Market
37. Mexico Urolithiasis Management Devices Market
38. Spain Urolithiasis Management Devices Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. Advanced MedTech Holdings
40.2. AKSM, Ltd.
40.3. Avvio Medical, Inc.
40.4. Becton, Dickinson and Company
40.5. Boston Scientific Corporation
40.6. Calyxo Inc.
40.7. Coloplast A/S
40.8. Cook Group Incorporated
40.9. DirexGroup
40.10. Dornier MedTech GmbH
40.11. Dyne Medical Group Inc.
40.12. E.M.S. Electro Medical Systems S.A.
40.13. EDAP TMS SA
40.14. Elmed Lithotripsy Systems
40.15. EndoTheia, Inc.
40.16. Karl Storz GmbH & Co. KG
40.17. Nissha Medical Technologies
40.18. Olympus Corporation
40.19. Quanta System S.p.A.
40.20. Richard Wolf GmbH
40.21. Siemens Healthineers
40.22. SonoMotion
40.23. Teleflex Incorporated
List of Figures
FIGURE 1. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 23. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GUIDEWIRES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GUIDEWIRES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GUIDEWIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL LITHOTRIPTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL LITHOTRIPTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL LITHOTRIPTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL URETEROSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL URETEROSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL URETEROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL INTRACORPOREAL LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL INTRACORPOREAL LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL INTRACORPOREAL LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL METAL-BASED DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL METAL-BASED DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL METAL-BASED DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL POLYMER-BASED DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL POLYMER-BASED DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL POLYMER-BASED DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BLADDER STONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BLADDER STONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BLADDER STONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL KIDNEY STONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL KIDNEY STONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL KIDNEY STONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL URETERAL STONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL URETERAL STONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL URETERAL STONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 60. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 61. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 62. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 63. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 64. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 66. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 67. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 68. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 69. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 84. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 85. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 86. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 90. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 91. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 93. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 96. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 97. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 98. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 99. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 102. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 103. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 104. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 105. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 106. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 108. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 109. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 110. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 111. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 114. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 115. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 116. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 120. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 121. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 122. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 126. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 127. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 128. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 129. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 131. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 132. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 133. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 134. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 137. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 138. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 139. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 140. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 143. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 144. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 145. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 146. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 149. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 150. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 151. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 152. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 155. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 156. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 157. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 158. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 161. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 162. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 163. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 164. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 167. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 168. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 169. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 170. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 173. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 174. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 175. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 176. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 179. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 180. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 181. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 182. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 185. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 186. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 187. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 188. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 189. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 191. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 192. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 193. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 194. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 197. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 198. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 199. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 200. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 203. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 204. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 205. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 206. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 207. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 209. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 210. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 211. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 212. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 215. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 216. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 217. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
TABLE 218. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Urolithiasis Management Devices market report include:
  • Advanced MedTech Holdings
  • AKSM, Ltd.
  • Avvio Medical, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Calyxo Inc.
  • Coloplast A/S
  • Cook Group Incorporated
  • DirexGroup
  • Dornier MedTech GmbH
  • Dyne Medical Group Inc.
  • E.M.S. Electro Medical Systems S.A.
  • EDAP TMS SA
  • Elmed Lithotripsy Systems
  • EndoTheia, Inc.
  • Karl Storz GmbH & Co. KG
  • Nissha Medical Technologies
  • Olympus Corporation
  • Quanta System S.p.A.
  • Richard Wolf GmbH
  • Siemens Healthineers
  • SonoMotion
  • Teleflex Incorporated

Table Information